Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Cash Flows From Operating activities
Net income	$ 2,821,299	$ 2,957,234
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,097,404	670,219
Provision for obsolete inventory	33,251	32,936
Asset impairment and store closure losses	178,000
Provision for loss on accounts and notes receivable	192,137	212,400
Gain on sale of property and equipment	(6,524)	(907)
Expense recorded for stock compensation	700,526	488,638
Deferred income taxes	(250,075)	4,303
Changes in operating assets and liabilities:
Accounts receivable	307,530	(613,566)
Inventories	(208,403)	(36,687)
Other current assets	23,649	(211,981)
Accounts payable	(190,245)	(1,050,447)
Accrued liabilities	278,639	(896,897)
Deferred income	(491,115)	25,502
Net cash provided by operating activities	4,486,073	1,580,747
Cash Flows From Investing Activities
Addition to notes receivable	(163,396)	(684,098)
Proceeds received on notes receivable	383,208	231,614
Proceeds from sale or distribution of assets	531,345	2,600
Purchases of property and equipment	(446,166)	(1,112,431)
Increase in other assets	(8,786)	(7,352)
Net cash provided by (used) in investing activities	296,205	(1,569,667)
Cash Flows From Financing Activities
Repurchase of common stock	(1,904,829)
Issuance of common stock	69,599	14,816
Proceeds from issuance of common stock in subsidiary	892,895
Tax benefit of stock awards	200,544	68,832
Dividends paid	(2,039,911)	(2,009,108)
Net cash used in financing activities	(2,781,702)	(1,925,460)
Net Increase (Decrease) in Cash and Cash Equivalents	2,000,576	(1,914,380)
Cash and Cash Equivalents, Beginning of Period	5,859,729	5,321,696
Cash and Cash Equivalents, End of Period	$ 7,860,305	$ 3,407,316